Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07749690

Mental Rotation and Motor Imagery Training in Multiple Sclerosis

Conditions: Relapsing Remitting MS (RRMS)

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 54
Sponsor: Abant Izzet Baysal University

Location: Abant Izzet Baysal University Faculty of Health Science Bolu

Summary

This randomized controlled trial investigated the effects of sequential laterality, motor imagery, and mental rotation training in individuals with relapsing-remitting multiple sclerosis. Both groups received conventional physiotherapy, while the intervention group received structured cognitive-motor training and the control group received active visual-attention training.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with definite relapsing-remitting multiple sclerosis by a neurologist according to the revised McDonald criteria * Not experiencing an acute MS relapse * Mini Mental State Examination score ≥24 * No clinical MS relapse within the previous 3 months * No corticosteroid treatment for an MS relapse within the previous 3 months * Expanded Disability Status Scale score between 1.5 and 6.0 * Modified Ashworth Scale score ≤2 * Sufficient communication ability to understand visual and verbal instructions and follow the training protocol * Able to attend at least 80% of the planned sessions * Able to complete the Movement Imagery Questionnaire-3 Exclusion Criteria: * Any medication change within the previous 3 months * Uncorrected severe visual or hearing impairment * A communication disorder preventing the perception of or response to the visual and verbal stimuli used in the study * Participation in another structured upper-extremity rehabilitation program or interventional study during the study period * Presence of an additional neurological disorder * Advanced sensory loss or proprioceptive impairment that could affect participation in the intervention * Botulinum toxin injection within the previous 3 months

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07749690). StuddyBuddy aggregates publicly available trial information.